High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)

By sjmartinez • April 29, 2025

Riddler SA, Moodie Z, Clark J, Yen C, Allen M, Furch BD, Lu H, Grant S, Mondal K, Anderson M, Maenza J, Lemos MP, Woodward Davis AS, Walsh SR, Sobieszczyk ME, Frank I, Goepfert P, Stephenson KE, Baden LR, Tieu HV, Keefer MC, McElrath MJ, Kublin JG, Corey L. High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302). Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-02701. Epub ahead of print. PMID: 40294415.

Tags: Infectious Diseases, Publications

Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses

Smith D, Weir IR, Ramirez S, Coelho CH, Manne-Goehler J, Aziz M, Benson CA, Wu X, Hyer R, Dhillon PK, Faraji F, Bloom N, Myers[...]

Feeling the Vibes: An Investigation Into Resident Antibiotic Prescribing Practices

Dickson DA, Jordan JM, Vijayan T. Feeling the Vibes: An Investigation Into Resident Antibiotic Prescribing Practices. Open Forum Infect Dis. 2026 Jan 23;13(2):ofag017. doi: 10.1093/ofid/ofag017.[...]

A cross-sectional study examining generalized anxiety disorder among healthcare workers during the COVID-19 pandemic within the Democratic Republic of the Congo

Martin SA, Nkamba DM, Hoff NA, Merritt S, Halbrook M, Tangney S, Ida N, Onya GM, Mutwadi A, Musene K, Luhata C, Kaba D, Rimoin[...]